Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Oncological Medicine
Volume 2016, Article ID 2672671, 4 pages
http://dx.doi.org/10.1155/2016/2672671
Case Report

Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation

1Department of Oncology, Goulburn Valley Health, Graham Street, Shepparton, VIC 3630, Australia
2Research Unit, Goulburn Valley Health, Shepparton, VIC 3630, Australia
3RHAC, Department of Rural Health, University of Melbourne, Shepparton, VIC 3630, Australia
4Department of Anatomy and Developmental Biology, Monash University, Melbourne, VIC 3800, Australia

Received 21 September 2015; Accepted 1 February 2016

Academic Editor: Francesco A. Mauri

Copyright © 2016 K. Sahadudheen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

K. Sahadudheen, Md. Rafiqul Islam, and M. Iddawela, “Long Term Survival and Continued Complete Response of Vemurafenib in a Metastatic Melanoma Patient with BRAF V600K Mutation,” Case Reports in Oncological Medicine, vol. 2016, Article ID 2672671, 4 pages, 2016. https://doi.org/10.1155/2016/2672671.